RANDOMIZED, DOUBLE-BLIND, PIVOTAL STUDY OF PHASE III OF THE IMMUNOGENICITY, SECURITY AND COMPARATIVE TOLERANCE OF TWO VACCINES 17D AGAINST YELLOW FEVER (ARILVAX TM AND YF-VAX TM) IN INFANTS AND HEALTHY CHILDREN IN PERU

Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2002
INTERVENTION: CONDITION: ‐A95 Yellow fever ; Yellow fever Yellow fever INCLUSION CRITERIA: * Age> 9 months to 10 years, also in good general health, with no medical history. * Absence of moderate or severe malnutrition according to the nomogram specific for each sex that the Ministry of Health of Peru offers to all the children.
Epistemonikos ID: 0a3d5945b884e23cc06944613143e3193802b029
First added on: Aug 25, 2024